Tuomas Knowles

This inventor holds 9 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: University of Cambridge, Harvard College. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tuomas Knowles. Retrieved from https://idiyas.com/inventor/tuomas-knowles

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 6)

% Patents Active = 88.9

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 18)

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 44(Granted Patents)

Location History:

Cambridge Cambridgeshire, GB (2019)
Cambridgeshire, GB (2018 - 2020)
Cambridge, GB (2020 - 2024)

Company Filing History:

9 out of 439

University of Cambridge

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545786 - Plant based functional materials (2026-02-10),

2. 11878080 - Protein capsules (2024-01-23),

3. 11536729 - Method of identifying novel protein aggregation inhibitors based on chemical kinetics (2022-12-27),

4. 10670504 - Fluidic device (2020-06-02),

5. 10620102 - Viscosity measurements based on tracer diffusion (2020-04-14),

6. 10386332 - Fluidic analysis and separation (2019-08-20),

7. 10295545 - Fluidic separation and detection (2019-05-21),

8. 9958369 - Fluidic device (2018-05-01),

9. 9952222 - Fluidic separation and detection (2018-04-24),

Title: Tuomas Knowles: A Pioneer in Protein Innovation

Introduction

Tuomas Knowles is an esteemed inventor located in Cambridgeshire, GB, known for his significant contributions to the field of protein science. With a remarkable portfolio of eight patents, his groundbreaking work focuses on protein aggregation and its implications in various medical applications.

Latest Patents

Among his latest innovations, Knowles has developed a patent for Protein Capsules. This invention details capsules featuring a shell made from protein assembly, with optional internal networks of protein aggregates. These capsules aim to utilize non-covalent interactions for enhanced efficacy, potentially leading to breakthroughs in protein-based treatments. Additionally, he holds a patent regarding a Method of Identifying Novel Protein Aggregation Inhibitors Based on Chemical Kinetics. This method encompasses techniques for discovering pharmacophores and inhibitors against protein aggregation, with promising medical uses for conditions related to protein misfolding.

Career Highlights

Tuomas Knowles has held positions in prominent organizations such as Cambridge Enterprise Limited and Harvard College. His work in these institutions has furthered his research capabilities and exposed him to a network of influential researchers and innovators in the field.

Collaborations

Throughout his career, Knowles has collaborated with distinguished colleagues, including Christopher Martin Dobson and Therese Herling. These partnerships have enriched his research and have been instrumental in advancing the understanding of protein interactions and their biological significance.

Conclusion

In summary, Tuomas Knowles stands out as a leading figure in protein innovation, with a strong commitment to addressing challenges associated with protein aggregation. His patents and collaborative efforts reflect a dedication to scientific advancement, paving the way for potential medical breakthroughs in treating diseases linked to protein misfolding.

Profile summary based on public USPTO records.